|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 801 PENNSYLVANIA AVE., NW #245 |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 290252-36
|
||||||||
|
6. House ID# 371850002
|
TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Richard Bringewatt |
Date | 4/18/2016 9:19:15 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Advocated for improving the predictive accuracy of MA payment rates for persons dually-eligible for Medicare and Medicaid. In particular, we advocated in support of the Administrations proposal to modify the CMS-HCC payment method to better account for the cost of caring for dual beneficiaries vs non-duals, and for full benefit duals in particular, which represent the poorest of the poor Medicare beneficiaries.
Promoted permanent or long-term extension of SNP legislative authority in conjunction with related SNP-related provisions. Permanency and related provisions are important to provide stability for plans and states involved in advancing specialized managed care programs and for special needs individuals. This will also improve the viability of SNPs in fulfilling their Congressional established specialty care mandate.
Advocated for changes in methods used to measure SNP performance under STARS to more effectively account for influences of social, education, and economic factors that affect health and health outcomes for persons dually-eligible for Medicare and Medicaid beyond what exists for persons of higher income, education, and social and economic status. Current provisions do not take these factors into account and penalize plans that seek to specialize in care of poor, frail, disabled, chronically ill persons.
Advocated for Congress to create a legislative/regulatory pathway to better align Medicare and Medicaid for persons dually-eligible for Medicare and Medicaid. Provisions will improve efficiency in program administration and improve methods for serving frail elders, adults with disabilities, and other persons with complex medical conditions, such as HIV/AIDS, ESRD, and SMPM. These are the most costly and complex care subgroups of the dually-eligible population.
Worked with the Medicare/Medicaid Coordination Office, Congress, and others towards advancing the integration of Medicare and Medicaid benefits and services for persons dually-eligible for Medicare and Medicaid.
Advocated for various proposals and changes to other proposals outlined by CMS in in their Advance Notice and Draft Call Letter for MA plans to be operating in 2017.
Advocated for improving policy for persons with chronic illness, given options being considered by the Senate Finance Committee in conjunction with the SFCs Chronic Care Working Group.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rich |
Bringewatt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |